FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Enrique Raviña

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Laura Carro; Enrique Raviña; Eduardo Domínguez; José Brea; M Isabel Loza; Christian F Masaguer
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
Raquel Ortega; Enrique Raviña; Christian F Masaguer; Filipe Miguel Areias; José Brea; M Isabel Loza; Laura López; Jana Selent; Manuel Pastor; Ferran Sanz
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
Reyes Aranda; Karen Villalba; Enrique Raviña; Christian F Masaguer; José Brea; Filipe Miguel Areias; Eduardo Domínguez; Jana Selent; Laura López; Ferran Sanz; Manuel Pastor; M Isabel Loza
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Enrique Raviña (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Laura Carro; Enrique Raviña; Eduardo Domínguez; José Brea; M Isabel Loza; Christian F Masaguer
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
Bioorganic & medicinal chemistry letters 2009;19(21):6059-62.
2009: Raquel Ortega; Enrique Raviña; Christian F Masaguer; Filipe Miguel Areias; José Brea; M Isabel Loza; Laura López; Jana Selent; Manuel Pastor; Ferran Sanz
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
Bioorganic & medicinal chemistry letters 2009;19(6):1773-8.
2008: Reyes Aranda; Karen Villalba; Enrique Raviña; Christian F Masaguer; José Brea; Filipe Miguel Areias; Eduardo Domínguez; Jana Selent; Laura López; Ferran Sanz; Manuel Pastor; M Isabel Loza
Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
Journal of medicinal chemistry 2008;51(19):6085-94.
2008: Angela Stefanachi; Jose Manuel Brea; María Isabel Cadavid; Nuria B Centeno; Cristina Esteve; M Isabel Loza; Ana Martinez; Rosa Nieto; Enrique Raviña; Ferran Sanz; Victor Segarra; Eddy Sotelo; Bernat Vidal; Angelo Carotti
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
Bioorganic & medicinal chemistry 2008;16(6):2852-69.
2008: Ana Martínez; Hugo Gutierrez de teran; José Brea; Enrique Raviña; M Isabel Loza; María Isabel Cadavid; Ferran Sanz; Bernat Vidal; Victor Segarra; Eddy Sotelo
Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2'-furyl)-1,2,4-triazolo[1,5-a]quinoxalines.
Bioorganic & medicinal chemistry 2008;16(4):2103-13.
2007: Alberto Coelho; Enrique Raviña; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Eddy Sotelo
Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Journal of medicinal chemistry 2007;50(26):6476-84.
2007: María Barceló; Enrique Raviña; Christian F Masaguer; Eduardo Domínguez; Filipe Miguel Areias; José Brea; M Isabel Loza
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
Bioorganic & medicinal chemistry letters 2007;17(17):4873-7.
2007: Cristina Dezi; José Brea; Mario Alvarado; Enrique Raviña; Christian F Masaguer; M Isabel Loza; Ferran Sanz; Manuel Pastor
Multistructure 3D-QSAR studies on a series of conformationally constrained butyrophenones docked into a new homology model of the 5-HT2A receptor.
Journal of medicinal chemistry 2007;50(14):3242-55.
2006: José Brea; Marian Castro; M Isabel Loza; Christian F Masaguer; Enrique Raviña; Cristina Dezi; Manuel Pastor; Ferran Sanz; Araceli Cabrero-Castel; Beatriz Galán-Rodríguez; Emilio Fernández-Espejo; Rafael Maldonado; Patricia Robledo
QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
Neuropharmacology 2006;51(2):251-62.
2006: Abel Crespo; Caroline Meyers; Alberto Coelho; Matilde Yáñez; Matilde Yañez; Eddy Sotelo; Bert U W Maes; Reyes Laguna; Ernesto Cano; Guy Lemière; Enrique Raviña
Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
Bioorganic & medicinal chemistry letters 2006;16(4):1080-3.
2006: Angelo Carotti; María Isabel Cadavid; Nuria B Centeno; Cristina Esteve; M Isabel Loza; Ana Martinez; Rosa Nieto; Enrique Raviña; Ferran Sanz; Victor Segarra; Eddy Sotelo; Angela Stefanachi; Bernat Vidal
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
Journal of medicinal chemistry 2006;49(1):282-99.
2006: Mario Alvarado; María Barceló; Laura Carro; Christian F Masaguer; Enrique Raviña
Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics.
Chemistry & biodiversity 2006;3(1):106-17.
2005: Mario Alvarado; Alberto Coelho; Christian F Masaguer; Enrique Raviña; José Brea; J Fernando Padín; M Isabel Loza
Synthesis and binding affinity of novel 3-aminoethyl-1-tetralones, potential atypical antipsychotics.
Bioorganic & medicinal chemistry letters 2005;15(12):3063-6.
2004: Angelo Carotti; Angela Stefanachi; Enrique Raviña; Eddy Sotelo; M Isabel Loza; María Isabel Cadavid; Nuria B Centeno; Orazio Nicolotti
8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B.
European journal of medicinal chemistry 2004;39(10):879-87.
2004: Yolanda Caro; María Torrado; Christian F Masaguer; Enrique Raviña; Fernando Padín; José Brea; M Isabel Loza
Chemoenzymatic synthesis and binding affinity of novel (R)- and (S)-3-aminomethyl-1-tetralones, potential atypical antipsychotics.
Bioorganic & medicinal chemistry letters 2004;14(3):585-9.
2004: Alberto Coelho; Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Bioorganic & medicinal chemistry letters 2004;14(2):321-4.
2003: Rosa Maria Nieto; Alberto Coelho; Ana Martínez; Angela Stefanachi; Eddy Sotelo; Enrique Raviña
Synthesis of 1-substituted-6-methyluracils.
Chemical & pharmaceutical bulletin 2003;51(9):1025-8.
2003: José Brea; Christian F Masaguer; María Villazón; María Isabel Cadavid; Enrique Raviña; Fabien Fontaine; Cristina Dezi; Manuel Pastor; Ferran Sanz; M Isabel Loza
Conformationally constrained butyrophenones as new pharmacological tools to study 5-HT 2A and 5-HT 2C receptor behaviours.
European journal of medicinal chemistry 2003;38(4):433-40.
2003: Eddy Sotelo; Alberto Coelho; Enrique Raviña
Pyridazine derivatives 32: Stille-based approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Chemical & pharmaceutical bulletin 2003;51(4):427-30.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
Chemical & pharmaceutical bulletin 2002;50(12):1574-7.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Vicente Terrades; Reyes Laguna; Ernesto Cano; Enrique Raviña
Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
Bioorganic & medicinal chemistry 2002;10(9):2873-82.
2002: Eddy Sotelo; Matilde Yañez; Matilde Yáñez; Reyes Laguna; Ernesto Cano; José Brea; Enrique Raviña
Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
Bioorganic & medicinal chemistry letters 2002;12(12):1575-7.
2002: José Brea; Jordi Rodrigo; Antonio Carrieri; Ferran Sanz; María Isabel Cadavid; María José Enguix; María Villazón; Guadalupe Mengod; Yolanda Caro; Christian F Masaguer; Enrique Raviña; Nuria B Centeno; Angelo Carotti; M Isabel Loza
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
Journal of medicinal chemistry 2002;45(1):54-71.
2000: Enrique Raviña; I Casariego; Christian F Masaguer; Jose A Fontenla; GY Montenegro; ME Rivas; M Isabel Loza; María José Enguix; M Villazon; María Isabel Cadavid; Gian Carlo Demontis
Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Journal of medicinal chemistry 2000;43(24):4678-93.
2000: Francisco Orallo; H Tristan; T Garcia-Ferreiro; S De Francisco; Christian F Masaguer; Enrique Raviña; José María Calleja; I Cadavid; M Isabel Loza
Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: implication of 5-HT2A and alpha1 adrenergic antagonism in their hypotensive effect.
Biological & pharmaceutical bulletin 2000;23(5):558-65.
2000: Christian F Masaguer; Enrique Raviña; Jose A Fontenla; José Brea; Helena Tristán; M Isabel Loza
Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: synthesis and determination of affinities at D(2), 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
European journal of medicinal chemistry 2000;35(1):83-95.
1999: A Montero-Lastres; Nuria Fraiz; Reyes Laguna; Ernesto Cano; I Estevez; Enrique Raviña
Pyridazines. XVIII. 6-Aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets.
Biological & pharmaceutical bulletin 1999;22(12):1376-9.
1999: Enrique Raviña; J Negreira; J Cid; Christian F Masaguer; E Rosa; ME Rivas; Jose A Fontenla; M Isabel Loza; Helena Tristán; María Isabel Cadavid; Ferran Sanz; Estrella Lozoya; Angelo Carotti; Antonio Carrieri
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Journal of medicinal chemistry 1999;42(15):2774-97.
1998: Christian F Masaguer; E Formoso; Enrique Raviña; Helena Tristán; M Isabel Loza; Emilia Rivas; Jose A Fontenla
Butyrophenone analogues in the carbazole series: synthesis and determination of affinities at D2 and 5-HT2A receptors.
Bioorganic & medicinal chemistry letters 1998;8(24):3571-6.
1998: Manuel Campos-Toimil; I Estévez; Enrique Raviña; Francisco Orallo
Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: comparison with hydralazine.
General pharmacology 1998;30(2):201-7.
1997: Reyes Laguna; B Rodriguez-Liñares; Ernesto Cano; I Estevez; Enrique Raviña; Eddy Sotelo
Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
Chemical & pharmaceutical bulletin 1997;45(7):1151-5.
1996: Enrique Raviña; J Fueyo; Christian F Masaguer; J Negreira; J Cid; I Loza; A Honrubia; Helena Tristán; T G-Ferreiro; Jose A Fontenla; E Rosa; José María Calleja; M L De Ceballos
Synthesis and affinities for dopamine (D2) and 5-hydroxytryptamine (5-HT2A) receptors of 1-(benzoylpropyl)-4-(1-oxocycloalkyl-2-ethyl)-piperazines as cyclic butyrophenone derivatives.
Chemical & pharmaceutical bulletin 1996;44(3):534-41.
1994: Jose A Fontenla; J Osuna; E Rosa; M E Castro; T G-Ferreiro; I Loza-García; José María Calleja; Ferran Sanz; J Rodríguez; Enrique Raviña
Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
Journal of medicinal chemistry 1994;37(16):2564-73.
1989: R M Sánchez-Alonso; Enrique Raviña; Lourdes Santana; G García-Mera; Manuel L Sanmartín; P Baltar
Piperazine derivatives of benzimidazole as potential anthelmintics. Part 1: Synthesis and activity of methyl-5-(4-substituted piperazin-1-yl)benzimidazole-2-carbamates.
Die Pharmazie 1989;44(9):606-7.
1989: Carmen Terán; Enrique Raviña; Lourdes Santana; N García-Domínguez; G García-Mera; Jose A Fontenla; Francisco Orallo; José María Calleja
Pyridazine derivatives, VII. Synthesis and hypotensive activity of 3-hydrazinocycloalkyl[1,2-c]pyridazines and their derivatives.
Archiv der Pharmazie 1989;322(6):331-6.
1989: Lourdes Santana; L Cortizo; Eugenio Uriarte; N Garcia-Dominquez; Enrique Raviña; M J Garrido
Preparation of beta-aminomethyl-beta-benzoylpropionic acids and related cis beta-aminomethyl-gamma-phenyl-gamma-butyrolactones as potential antibacterial agents.
Journal de pharmacie de Belgique 1989;44(2):121-6.
1988: N García-Dominguez; Enrique Raviña; Lourdes Santana; Carmen Terán; G García-Mera; Francisco Orallo; M Crespo; Jose A Fontenla
Pyridazine derivatives, VI. Synthesis and hypotensive activity of 3-hydrazinethieno(2,3-h)cinnoline and its derivatives.
Archiv der Pharmazie 1988;321(10):735-8.
1985: Francisco Orallo; José María Calleja; G García Mera; Enrique Raviña
[Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
Archivos de farmacología y toxicología 1985;11(3):171-82.
1985: E Cano; José María Calleja; R García Ramos; Enrique Raviña; Lourdes Santana; A M Eirin
[Synthesis and analgesic and anti-inflammatory activity of various beta-aminomethyl-beta-benzoylpropionic acids].
Archivos de farmacología y toxicología 1985;11(2):99-108.